Disclosure Of First-Time Adoption [Text Block]

Xbrane Biopharma - Filing #702448

Concept As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
As at
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
Disclosure of first-time adoption [text block]
Disclosure of comparative information prepared under previous GAAP [text block]
Disclosure of comparative information prepared under previous GAAP [abstract]
Disclosure of comparative information prepared under previous GAAP [line items]
Equity
713 313 SEK
431 741 SEK
5 165 SEK
1 134 276 SEK
5 614 SEK
524 938 SEK
4 977 SEK
3 945 SEK
773 724 SEK
257 708 SEK
184 323 SEK
3 456 SEK
6 719 SEK
448 089 SEK
159 352 SEK
6 719 SEK
298 912 SEK
3 456 SEK
448 089 SEK
273 941 SEK
Comprehensive income
1 220 SEK
187 156 SEK
188 376 SEK
228 800 SEK
226 026 SEK
2 774 SEK
Profit (loss)
188 376 SEK
188 376 SEK
226 026 SEK
226 026 SEK

Talk to a Data Expert

Have a question? We'll get back to you promptly.